<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">339478</id>
  <title nil="true"/>
  <common-name>[3-[(4-formylpyridin-1-ium-1-yl)methoxymethyl]-4-[[4-[(e)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxy]butylidene]-[(4e)-4-hydroxyimino-3-[(e)-hydroxyiminomethyl]but-2-enylidene]azanium</common-name>
  <description>[3-[(4-formylpyridin-1-ium-1-yl)methoxymethyl]-4-[[4-[(e)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxy]butylidene]-[(4e)-4-hydroxyimino-3-[(e)-hydroxyiminomethyl]but-2-enylidene]azanium is a compound with the formula C24H29N6O6+3. It has an average molecular weight of 497.50 g/mol.</description>
  <cas nil="true"/>
  <pubchem-id>135959069</pubchem-id>
  <chemical-formula>C24H29N6O6+3</chemical-formula>
  <weight>497.5</weight>
  <appearance nil="true"/>
  <melting-point nil="true"/>
  <boiling-point nil="true"/>
  <density nil="true"/>
  <solubility nil="true"/>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity nil="true"/>
  <use-source nil="true"/>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2026-08-30T22:48:08Z</created-at>
  <updated-at type="dateTime">2026-08-30T22:48:08Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia nil="true"/>
  <uniprot-id nil="true"/>
  <kegg-compound-id nil="true"/>
  <omim-id nil="true"/>
  <chebi-id nil="true"/>
  <biocyc-id nil="true"/>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id nil="true"/>
  <pdb-id nil="true"/>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>C1=C[N+](=CC=C1C=NO)COCC(CC=[N+]=CC=C(C=NO)C=NO)COC[N+]2=CC=C(C=C2)C=O</moldb-smiles>
  <moldb-formula>C24H29N6O6+3</moldb-formula>
  <moldb-inchi>InChI=1S/C24H26N6O6/c31-16-22-5-11-30(12-6-22)20-36-18-24(2-8-25-7-1-23(14-27-33)15-28-34)17-35-19-29-9-3-21(4-10-29)13-26-32/h1,3-16,24H,2,17-20H2/p+3</moldb-inchi>
  <moldb-inchikey>ZUIXQFBZAUHZJT-UHFFFAOYSA-Q</moldb-inchikey>
  <moldb-average-mass type="decimal" nil="true"/>
  <moldb-mono-mass type="decimal">497.2148577</moldb-mono-mass>
  <origin nil="true"/>
  <state nil="true"/>
  <logp nil="true"/>
  <hmdb-id nil="true"/>
  <chembl-id nil="true"/>
  <chemspider-id nil="true"/>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference nil="true"/>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM335371</chemdb-id>
  <dsstox-id nil="true"/>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id nil="true"/>
  <iupac>[3-[(4-formylpyridin-1-ium-1-yl)methoxymethyl]-4-[[4-[(e)-hydroxyiminomethyl]pyridin-1-ium-1-yl]methoxy]butylidene]-[(4e)-4-hydroxyimino-3-[(e)-hydroxyiminomethyl]but-2-enylidene]azanium</iupac>
  <moldb-polar-surface-area nil="true"/>
  <moldb-refractivity nil="true"/>
  <moldb-polarizability nil="true"/>
  <moldb-rotatable-bond-count nil="true"/>
  <moldb-acceptor-count nil="true"/>
  <moldb-donor-count nil="true"/>
  <moldb-pka-strongest-acidic nil="true"/>
  <moldb-pka-strongest-basic nil="true"/>
  <moldb-physiological-charge nil="true"/>
  <moldb-number-of-rings nil="true"/>
  <moldb-alogps-logp nil="true"/>
  <moldb-alogps-logs nil="true"/>
  <moldb-alogps-solubility nil="true"/>
  <kingdom>Organic compounds</kingdom>
  <superklass>Organoheterocyclic compounds</superklass>
  <klass>Pyridines and derivatives</klass>
  <subklass>Pyridine carboxaldehydes</subklass>
  <paper-count type="integer" nil="true"/>
  <sync-id>CED0289898</sync-id>
  <structure-inchikey>ZUIXQFBZAUHZJT-UHFFFAOYSA-Q</structure-inchikey>
  <structure-fingerprint>40000000000000020000800000000200000000040000000000000000010000000002000000000000000001040000000010000000000000000001000001000000000000000000000000000000000000000020000000000300000004000000000000000200010400000004000080000000000000000800080010000000001800000000000005800800080000000000000004004000000000000000000000000000000000000100000000000000080000000008000000010000000000000000000000000000000000040000000000000000000800001000000000000200000200000000000000000000000040000000001000000101000001000080000020004000</structure-fingerprint>
  <structure-pattern-fingerprint>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</structure-pattern-fingerprint>
  <structure-pickle type="binary" encoding="base64">776t3gAAAAAQAAAAAwAAAAAAAAAkAAAAJQAAAIABBkBoAAAAAwMBBkBoAAAA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</structure-pickle>
  <structure-indexed-at type="dateTime">2026-09-19T05:39:58Z</structure-indexed-at>
</compound>
